Arrowhead Pharmaceuticals Inc (ARWR)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$63.51
Buy
$63.59
$-1.11 (-1.72%)
Prices updated at 17 Dec 2025, 19:53 EST
| Prices minimum 15 mins delay
Prices in USD
Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 10.43 |
| 2024 | 634.17 |
| 2023 | 13.64 |
| 2022 | 17.67 |
| 2021 | 49.74 |
| 2020 | 87.83 |
| 2019 | 37.05 |
| 2018 | 64.35 |
| 2017 | 8.66 |
| 2016 | 597.66 |
| 2015 | 923.44 |
Price/Forward earnings (YTD)
-28.41
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | -0.13 |
| 2024 | -62.93 |
| 2023 | -28.17 |
| 2022 | -25.11 |
| 2021 | -22.85 |
| 2020 | -19.39 |
| 2019 | 29.46 |
| 2018 | -50.50 |
| 2017 | -29.61 |
| 2016 | -62.76 |
| 2015 | -58.36 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 2.97 |
| 2024 | 6.15 |
| 2023 | 2.82 |
| 2022 | 1.74 |
| 2021 | 1.74 |
| 2020 | 1.13 |
| 2019 | 1.43 |
| 2018 | 1.17 |
| 2017 | 1.28 |
| 2016 | 1.34 |
| 2015 | 1.20 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
